Griffin et al., 1983 - Google Patents
Characterization of an antigen expressed by human natural killer cells.Griffin et al., 1983
- Document ID
- 18200524871771426500
- Author
- Griffin J
- Hercend T
- Beveridge R
- Schlossman S
- Publication year
- Publication venue
- Journal of immunology (Baltimore, Md.: 1950)
External Links
Snippet
A monoclonal antibody, anti-N901, was produced by fusing NS-1 myeloma cells with spleen cells of a mouse immunized with human CML cells. This antibody was reactive with a subpopulation of peripheral blood LGL, including the natural killer cells. Monocytes …
- 239000000427 antigen 0 title abstract description 65
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Griffin et al. | Characterization of an antigen expressed by human natural killer cells. | |
| Perussia et al. | Human natural killer cells analyzed by B73. 1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73. 1. | |
| Janossy et al. | Distribution of t lymphocyte subsets in the human bone marrow and thymus: an analysis with monoclonal antibodies. | |
| Hercend et al. | Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. | |
| Andrews et al. | Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies | |
| Perussia et al. | The Fc receptor for IgG on human natural killer cells: phenotypic, functional, and comparative studies with monoclonal antibodies. | |
| Phillips et al. | Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens. | |
| Bernstein et al. | Normal and malignant human myelocytic and monocytic cells identified by monoclonal antibodies. | |
| McGarry et al. | Murine eosinophil granulocytes bind the murine macrophage-monocyte specific monoclonal antibody F4/80 | |
| Abo et al. | Characterization of HNK-1+(Leu-7) human lymphocytes. II. Distinguishing phenotypic and functional properties of natural killer cells from activated NK-like cells. | |
| Abo et al. | A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). | |
| London et al. | Induction of proliferation in vitro of resting human natural killer cells: expression of surface activation antigens. | |
| Fox et al. | Ta1, a novel 105 KD human T cell activation antigen defined by a monoclonal antibody. | |
| Timonen et al. | Characteristics of human large granular lymphocytes and relationship to natural killer and K cells | |
| Steinhauer et al. | Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease. | |
| Ball et al. | A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody. | |
| CA1170593A (en) | Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor t cells, antibody, and methods | |
| IE881357L (en) | Monoclonal antibody specific for the adhesion function¹domain of a phagocyte cell surface protein | |
| NZ193173A (en) | Hybridoma for producing monoclonal antibody to human t cells;antibody;therapeutic compositions and diagnostic methods | |
| Zola et al. | Maturation of human B lymphocytes--studies with a panel of monoclonal antibodies against membrane antigens | |
| Jensen et al. | Expression of multiple β1 integrins on circulating monoclonal B cells in patients with multiple myeloma | |
| Gouttefangeas et al. | The CD39 molecule defines distinct cytotoxic subsets within alloactivated human CD8‐positive cells | |
| Starkebaum et al. | Chronic lymphocytosis with neutropenia: Evidence for a novel, abnormal T-cell population associated with antibody-mediated neutrophil destruction | |
| Lanier et al. | A human natural killer cell-associated antigen defined by monoclonal antibody anti-Leu (NKP-15): functional and two-color flow cytometry analysis | |
| Kedar et al. | Propagation of mouse cytotoxic clones with characteristics of natural killer (NK) cells |